Fast Market Research

New Market Research Report: Global PCOS Drugs Market 2014-2018

New Pharmaceuticals market report from TechNavio: "Global PCOS Drugs Market 2014-2018"

 
Repost This

Boston, MA -- (SBWIRE) -- 07/14/2014 -- PCOS, also known as Stein-Leventhal Syndrome, is one of the most common hormonal endocrine disorders in women. It is characterized by polycystic ovaries, irregular or no menstrual periods, irregular ovulation, and high levels of androgens (male hormones) in the body. The exact cause of PCOS is unknown. In PCOS, small cysts form on the ovaries, which do not produce a sufficient amount of hormone to initiate ovulation. The ovarian follicles, which are filled with fluid in preparation for ovulation, remain as cysts when ovulation does not occur. Lifestyle modifications, medication, and surgery are some of the currently available treatments for PCOS.

TechNavio's analysts forecast the Global PCOS Drugs market will grow at a CAGR of 2.65 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global PCOS Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of marketed, off-label, and generic drugs used in the treatment of PCOS.

View Full Report Details and Table of Contents

TechNavio's report, the Global PCOS Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global PCOS Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas
- EMEA
- APAC

Key Vendors

- Bristol Myers Squibb Co.
- Merck & Co. Inc.
- Novartis AG
- Sanofi SA
- Teva Pharmaceutical Inc.

Other Prominent Vendors

- AstraZeneca plc
- Catalysis SL
- Crinetics Pharmaceuticals Inc.
- Dexa Medica Group
- EffRx Inc.
- Neurocrine Biosciences Inc.

Market Driver

- Increase in Patient Population.
- For a full, detailed list, view our report.

Market Challenge

- Lack of Approved Drugs.
- For a full, detailed list, view our report.

Market Trend

- Increase in Awareness of PCOS Drugs.
- For a full, detailed list, view our report.

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: NeoStrata Co., NuSKin Enterprises, Orlane SA, Revlon Inc., Robanda International Inc., Shiseido Co., SkinMedica Inc., Skinvisible Inc., Woodridge Labs Inc., Bristol Myers Squibb Co., Merck & Co. Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Inc., AstraZeneca plc, Catalysis SL, Crinetics Pharmaceuticals Inc., Dexa Medica Group, EffRx Inc., Neurocrine Biosciences Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Global Generic Drugs Market 2014-2018
- Global Pain Management Drugs Market 2014-2018
- Global CRAMS Market Outlook to 2018 - India and China Present Bright Prospects
- Global Dermatological Drugs Market 2014-2018
- Biosimilars Market - Global Forecast to 2018
- Global Orphan Drugs Market 2014-2018
- Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat
- Global Osteoporosis Drugs Market 2014-2018
- Global Non-melanoma Skin Cancer Market 2014-2018
- Global Depression Drugs Market 2014-2018